Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.

Mere days after Jim Cramer praised FedEx (NYSE: FDX) as a “great stock to own,” the company’s shares took a nosedive.

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

'Mad Money' host Jim Cramer weighs in on stock including: Viking Holdings, Gentex, Cadre, and Celsius Holdings.

CNBC’s Jim Cramer on Thursday reviewed stocks that have historically performed well just after the a cutting cycle starts and endorsed his favorites.

T-Mobile Chief Executive Mike Sievert says it’s “nonsense” that the iPhone 16 line’s preorder sales are underwhelming so far.